Riskpilot← Back to searchSign inGet full accessREVETALGÅRDEN FYSIOTERAPI AS
ASActiveOrg 999652719Revetalgata 10, 3174 RevetalPhysiotherapy activities · NACE 8695Est. 20131 employees
Revenue 2024
NOK 766K
+6% vs 2023
EBITDA margin
-3.9%
-194% vs 2023
Equity ratio
14.9%
Financial strength
Net profit 2024
NOK -30K
-194% vs 2023
| Revenue | NOK 766K | +6% |
| EBITDA | NOK -30K | -194% |
| Net profit | NOK -30K | -194% |
| Total assets | NOK 144K | -15% |
| Equity | NOK 21K | -58% |
| Employees | 1 | — |
Legal name
REVETALGÅRDEN FYSIOTERAPI AS
Org number
999652719
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
6. februar 2013
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Tjenester innenfor fysioterapi, osteopati og andre helserelaterte behandlinger. Salg av treningsutstyr. Kjøp, salg, utvikling og utleie av fast eiendom. Samt delta som aksjonær andelshaver eller på annen måte i selskaper med økonomiske formål.
Address
Revetalgata 10, 3174 Revetal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 606 | 600 | 600 | 720 | 766 |
| Staff expenses | −0 | −37 | −63 | −108 | −130 |
| EBITDA | 90 | −42 | −75 | 32 | −30 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 90 | −42 | −75 | 32 | −30 |
| Net financials | −0 | −0 | −0 | −0 | 0 |
| Profit before tax | 90 | −42 | −75 | 32 | −30 |
| Tax | 13 | −0 | −0 | −0 | −0 |
| Net profit | 78 | −42 | −75 | 32 | −30 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 244 | 192 | 152 | 169 | 144 |
| Equity | 136 | 94 | 19 | 51 | 21 |
| Long-term debt | 0 | 0 | 0 | 100 | 100 |
| Short-term debt | 108 | 97 | 133 | 18 | 22 |
| Total debt | 108 | 97 | 133 | 118 | 122 |
EBITDA margin
-3.9%
This company
15.8%
Market median
-125% vs market
20202024
Equity ratio
14.9%
This company
38.2%
Market median
-61% vs market
20202024
Return on equity
-138.8%
This company
18.4%
Market median
-854% vs market
20202024
Net profit margin
-3.9%
This company
8.1%
Market median
-148% vs market
20202024
Asset turnover
5.33×
This company
1.12×
Market median
+376% vs market
20202024
Debt / equity
5.71×
This company
0.62×
Market median
-821% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
KI Chief Executive Officer | Chief Executive Officer | 2013 |
AK Deputy Member | Deputy Member | 2013 |
JE Deputy Member | Deputy Member | 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2013 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of REVETALGÅRDEN FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjell Idar Wiig Ødegård | Chief Executive Officer | 0 companies |
| Anne Karine Ødegård | Deputy Member | 0 companies |
| John Egil Gahrsen | Deputy Member | 0 companies |
| Kjersti Huneide Gahrsen | Chairman | 0 companies |